Published in

BMJ Publishing Group, Tobacco Control, 2(31), p. 212-215, 2022

DOI: 10.1136/tobaccocontrol-2021-056918

Links

Tools

Export citation

Search in Google Scholar

Success from failure: US federal commercial tobacco regulation

Journal article published in 2022 by Desmond Jenson ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

The history of the US Food and Drug Administration’s (FDA) regulation of tobacco products is fraught with failures. A first effort to regulate tobacco products was completely dismantled. Despite robust authority to act, the current iteration of the FDA has also struggled to succeed. While the public health community may be frustrated by the lack of progress to date, recent developments have potentially shown advocates a pathway for success.